Ajay Yekkirala

Ajay Yekkirala, PhD, is a prominent figure in the biotechnology and life sciences sectors, currently serving as Co-Founder and SVP, Head of Discovery at Superluminal Medicines Inc since July 2023. Prior experience includes roles as VP, Head of Biology at RA Capital Management, L.P., and Co-Founder & Chief Scientific Officer at Blue Therapeutics, where significant advancements in pain management and nerve regeneration were achieved. Academically, Ajay Yekkirala holds a postdoctoral fellowship in Neuroscience from Harvard Medical School and a PhD in Pharmacology from the University of Minnesota. Research expertise encompasses neuroimmunology, receptor biology, and drug discovery, evidenced by a robust publication record and innovative project leadership during tenures at prestigious institutions, including Children's Hospital Boston and Harvard Medical School.